Financial Daily from THE HINDU group of publications
Tuesday, Aug 17, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals


TIFAC ties up with industry for pharmacogenomics centre

Our Bureau

New Delhi , Aug. 16

THE Technology Information Forecasting and Assessment Council (TIFAC) recently tied up with companies including SRL Ranbaxy and Hewlett Packard to set up a Centre of Relevance and Excellence (CORE) on pharmacogenomics at the Karnataka-based Manipal Academy of Higher Education (MAHE).

Other companies that have contributed towards setting up the centre are the Bangalore-based Shrusthi Pharmaceuticals and Juggat Pharma, and the Hyderabad-based Silicon Insights.

Pharmacogenomics is a study aimed at developing effective and safe medications and doses that will be tailored to a person's genetic makeup. It studies how genes affect a person's response to drugs.

TIFAC has also decided to set up a CORE at the Delhi College of Engineering (DCE), which will be engaged in advanced research in fibre optics and optical communications.

Companies that have contributed towards establishing this centre include the Delhi-based Trinity Microsystems, the Mumbai-based Falcon Electro-Tek, and the Gurgaon-based Himachal Futuristic Communications, according to senior TIFAC officials. "While the MoU was signed recently, the centre will be opened up shortly," they added.

TIFAC COREs are set up with the resources pooled in from three itself, educational institutions and industry.

TIFAC puts in over 50 per cent in the initial setup cost. In terms of operating costs, the University concerned and industry together account for over 50 per cent.

"The idea is to make available the best of infrastructure in the labs of educational institutions and make the course material relevant as per the industry's needs," said an official.

TIFAC aims to set up around 30 COREs by the end of this year. It has around 17 COREs currently, spread across the country in areas of herbal drugs, agro and industrial biotechnology, and wireless technologies, among others.

Companies that have participated include Pepsi Foods, the Thapar group, IBM India and DSM Soft.

Areas targeted by TIFAC for excellence include food technology, chemical engineering, textile and leather technology and sensors.

More Stories on : Pharmaceuticals | Research & Development

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Focus on urban poor: Minister


Vegetation buffer to beat noise pollution?
Bill for 8-digit classification code for excise introduced
Barroso's EU agenda gets under way with new team
`Boston Scientific stents do well for Apollo Hospitals'
Govt plans cut in petrol, diesel duties
NPPA hikes price of diabetes drug
TIFAC ties up with industry for pharmacogenomics centre
BARC plans space for tech transfer within campus
Current comfort
New chief for NFC
Maintain service tax rate at 8 pc: ICAI
VAT empowered panel inducts 15 more State Ministers
Asia drives world fibre consumption
Weaving park plans yet to take off
Need to build global Indian textile brands stressed
Govt plans to review DTH norms
Broadcasters hiking stake to acquire cricket rights
Cable operators to go on strike from today
Cable TV viewers may have to shell out more
Say no to pay TV
US consultancy firm offers coaching for Indian students
CII marketing meet from tomorrow
Boost to limestone-based units in TN
Our concerns being addressed at WTO talks: Kamal Nath
Philatelic expo in Kolkata
APSFC okays 54 projects
Rubber imports up 65 pc in first quarter
Engg goods, jewellery boost exports
Travel cos luring senior citizens with special holiday packages
`Travel Now-Pay Later' from Tourism Malaysia



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line